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INTRODUCTION
Ghrelin is a peptide composed of 28 amino acids which was
originally isolated from human and rat stomach as an
endogenous ligand to the growth hormone secretagogue
receptor (GHSR) (1). Ghrelin peptide exists in two major
molecular forms: an acylated peptide at serine 3 form and an
unacylated one. Acylation, catalyzed by ghrelin O-
acyltransferase, is indispensable for ghrelin to bind to GHS-R1a
(2, 3). N-octanoylated serine 3 residue is essential for
stimulation of GH release (1). Non-acylated ghrelin was found
to be present in human serum in higher levels as compared to
acylated ghrelin. The former seemed to be devoid of any
endocrine action. However, it was able to exert cardiovascular
and anti-proliferative effect, probably by binding to different
GHSR subtypes (4, 5). Des-Gln14-ghrelin is another
endogenous ligand for the GHS-R1a resulting in alternative
splicing of ghrelin gene acylated at serine 3 (1).
The effects of ghrelin are mediated via a seven-
transmembrane G protein-coupled receptor -GHSR. Two
subtypes of this receptor have been identified so far: 1)
functionally active, high affinity GHS-R1a, signal transduction
form of the receptor and 2) the biologically inactive GHS-R1b,
lacking transmembrane domains 6 and 7 and thus being unable
to bind a ligand or transduce a signal (6, 7). Published data
indicated that both GHSRs were widely distributed, e.g. in
hypothalamus, pituitary, stomach, heart, lung, pancreas, kidney,
adipose tissue and immune system which suggested that ghrelin
exposed both peripheral and central effects (8, 9). However,
ghrelin may act through an additional, not yet examined
receptor. Data of Baldanzi et al. (10) showed that in
cardiomyocytes, ghrelin and des-acylated ghrelin exhibit an anti-
apoptotic effect through binding to a novel, unidentified receptor
that is distinct from GHSR-1a. They suggested that ghrelin
activity is not mediated by GHSR-1a because no expression of
GHSR-1a was detected in cardiomyocytes. Moreover, both
ghrelin and des-acylated ghrelin recognize a common high
binding site, although only ghrelin but not des-acylated ghrelin
binds to GHSR-1a receptor (1). The putative novel receptor is
expected to be highly similar to GHSR-1a, since it differs only
as its lack of ability to distinguish between esterified and non-
esterified ghrelin peptide. Whether such a receptor is encoded by
alternative splicing of GHSR-1a gene or by a distinct gene still
remains to be determined (10).
Ghrelin is a multifaceted hormone playing an important role
in the regulation of GH secretion, food intake, and energy
balance in vertebrates (11, 12). Ghrelin also stimulates insulin
release and regulates GH, adrenocorticotropic hormone
(ACTH), and prolactin (PRL) secretion. In addition, ghrelin
affects many physiological functions like sleep, gastric motility,
cardiovascular function and behavior, as well as cell
proliferation, production of pro-inflammatory cytokines and
glucose (9, 13, 14) (Fig. 1). Several studies suggest that ghrelin
has also an important role in regulating female reproduction by
affecting the synthesis and secretion of reproductive hormones
from hypothalamus or pituitary, and by regulating ovarian
functions (15, 16). Recent study by Sirotkin et al. (17) indicates
the involvement of both hypothalamic and ovarian ghrelin/GHS-
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R1 systems in mediating the effects of nutritional status and
ghrelin on reproductive processes. Notwithstanding, only
limited research has addressed the physiology and role of ghrelin
in the hypothalamic-pituitary-ovarian axis in different species.
This mini-review summarizes the results of a series of new
studies on the effect of ghrelin on the hypothalamus, pituitary
and ovarian functions. Moreover, interaction between leptin and
kisspeptin has also been described.
GHRELIN AND THE HYPOTHALAMUS – PITUITARY AXIS
Ghrelin and the hypothalamus
The central nervous system, especially in the hypothalamus
and pituitary, contains primary sites of ghrelin action.
Expression of ghrelin in the hypothalamic arcuate nucleus
(ARC) appears to be an important region controlling appetite
(18). Injection of ghrelin into the rat cerebral ventricle III
stimulates food intake (19). Ghrelin containing-neurons
(hypothalamic neurons adjacent to the third ventricle between
the dorsal, ventral, para-ventricular, and ARC) project efferent
fibers to neurons that contain neuropeptide Y (NPY) and agouti-
related protein (AgRP) which might stimulate the release of
these orexigenic peptides. Peripheral administration of ghrelin
increases c-fos expression in the ARC NPY/AgRP neurons (20)
and ablation of both AgRP and NPY neurons completely
abolishes the orexigenic effect of ghrelin (21). GHS-R
expression has been localized to NPY-expressing cells with 90%
of ARC neurons co-expressing NPY and GHS-R (22, 23). GHS-
R is found to be expressed in the vagus nerve also. Furthermore,
blockade of gastric vagal afferents in rats abolishes ghrelin
induced feeding and prevents the ghrelin-induced rise in c-fos
expression within the ARC (24). Opposite effects to orexigenic
action of ghrelin appear in the form of leptin which exerts its
anorectic effect via the ARC, where both NPY/AgRP and pro-
opiomelanocortin (POMC)/cocaine- and amphetamine-regulated
transcript (CART) neurons express leptin receptors (25). Leptin
inhibits NPY/AgRP neurons and activates POMC/CART
neurons (26, 27), resulting in reduced food intake (26) and
increased energy expenditure (28). Electrophysiological studies
have shown that leptin inhibits a subpopulation of GHS-
responsive neurons (29) and that ghrelin acts directly on leptin-
responsive cells in the ARC (30). Thus, ghrelin and leptin act on
NPY and AgRP-co-expressing cells in the ARC in opposition to
one another (31, 32). Both ghrelin and leptin are involved in the
regulation of GHS-R in the ARC but not in the ventromedial
nuclei, with ghrelin increasing GHS-R expression but leptin
decreasing GHS-R mRNA (33). The relative sensitivity of the
hypothalamus to these orexigenic and anorectic signals therefore
is a key in the delicate balance of body weight regulation (33).
Moreover, interaction between leptin and ghrelin has influence
on the reproductive and food intake axes, which includes
interactions with neuropeptides that are also involved in
reproduction (34). It is well known fact that reproductive
function is highly dependent on food intake, body status or
metabolic disorders. For example, obesity can exert effects upon
the hypothalamic-pituitary-ovarian axis and as such disturb
menstrual cyclicity and ovulation. A large questionnaire study of
3 638 women demonstrated that menstrual cycle irregularity and
an ovulation were correlated with being overweight or obese
(35). Indeed, the grossly obese women had a rate of menstrual
disturbance 3.1 times that of women with normal weight (36).
Furthermore, obesity affects ovulation, oocyte maturation,
endometrial development, uterine receptivity, implantation and
miscarriage.
Ghrelin and gonadotropins secretion
Recenty it was propose that ghrelin is a possible signal of
energy deficiency for reproductive system (37). In
ovariectomized rats, ghrelin inhibits gonadotropin-releasing
hormone (GnRH) by hypothalamic fragments (38). Increasing
evidence supports an inhibitory effect of ghrelin in the
regulation of gonadotropin secretion (Table 1). Ghrelin was
found to significantly decrease the frequency of LH pulses in
ovarectomized rats (39), sheep (40), monkeys (41) and human
(42, 43). In addition, Fernandez-Fernandez et al. (44) showed
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that ghrelin inhibited LH secretion in gonadectomized rats,
whereas follicle-stimulating hormone (FSH) levels remained
unaffected. Moreover, ghrelin decreased LH responsiveness to
GnRH in vitro (45). Systematically administrated human
ghrelin attenuates the GnRH-induced preovulatory surge of
the gonadotropins in sheep (40). In ovariectomized rats, Ogata
et al. (46) demonstrated the suppressive effect of
intracerebroventricular injection of ghrelin on pulsative LH
secretion was mediated by beta-endorphin. Moreover,
preclinical studies have reported the inhibitory actions of
ghrelin on LH secretion in vivo and ghrelin’s ability to delay
onset of puberty (47). On the opposite side, other in vitro
experiments observed that ghrelin dose dependently
stimulated basal LH and FSH secretion by pituitary tissue of
adult female rats and this process required the presence of
nitric oxide and was modulated by ovarian signals (48).
Likewise, ghrelin stimulated LH secretion from cultured
pituitary cells from goldfish (49). In another study,
Sokolowska-Mikolajczyk et al. (50) demonstrated that ghrelin
increased LH secretion from cultured pituitary cells obtained
from sexually mature female carp (Cyprinuscarpio L.). In
contrast, in women during the menstrual cycle, administration
of ghrelin did not affect either basal or GnRH-induced LH and
FSH secretion (51). Additionally, ghrelin activity was strongly
dependent on experimental models. For example, Fernandez-
Fernandez et al. (38) in in vivo experiments demonstrated
inhibitory action of ghrelin on FSH and LH release in rats,
however, ghrelin dose dependently stimulated basal LH and
FSH release by pituitary tissue in vitro. This stimulation was
not present at estrous or after ovariectomy. These data
demonstrate a complex mode of action of ghrelin with
inhibitory effects at central level and direct stimulatory action
on basal gonadotropin secretion.
Some evidences suggest that ghrelin indirectly decreased
gonadotropin secretion by actions on central NPY, AgRP or
orexin expression (52, 53), which exhibit inhibitory effect on LH
secretion (15). Third-ventricular infusion of NPY suppressed LH
secretion (54) and estradiol enhances the effect of NPY on LH-
releasing hormone release in ovariectomized rhesus (55). On the
other side, Forbes et al. (56) demonstrated that ghrelin
administration significantly reduced LH pulsatility and
suppression of kisspeptin mRNA expression in ovariectomized
rats and suggested that down-regulation of kisspeptin expression
may play a critical role in the transduction of ghrelin-induced
suppression of reproduction function often observed during
calorific restriction. However, Kim et al. (57) demonstrated that
kisspeptin did not alter AgRP, ghrelin, Kiss1r mRNA expression
in the hypothalamic NPY-secreting cell lines (mHypoE-42 and
mHypoE-38 cells).
Ghrelin and prolactin secretion
Most studies have shown that ghrelin increased prolactin
(PRL) release through both central and peripheral actions. For
example, in normally cycling women, bromocriptine (suppresses
basal PRL secretion) blocked the stimulating effect of ghrelin on
PRL release (58). In human, ghrelin stimulated lactotrophs to
PRL secretion (59) and this effect is not additive with that of
dopamine receptor blocker, metoclopramide (60) and with that
of thyrotropin-releasing hormone (61). GHSR antagonism
prevented cortistatin-induced PRL secretion in vitro, and ghrelin
or GHSR agonists stimulated PRL release in humans (62, 63).
Further, Yang et al. (64) demonstrated that GHSR -/- mice have
reduced pituitary PRL mRNA and lactotroph cell number
supporting the above studies that ghrelin has stimulatory effect
on PRL secretion. On the other hand, in pre-pubertal rodents,
ghrelin administered centrally inhibited secretion of PRL (65).
Iqbal et al. (40) demonstrated that neither the infusion of ovine
ghrelin into the third cerebral ventricle nor bolus injections of
various doses of human DAP-octanoyl3 ghrelin had any effect
on plasma PRL levels in sheep. This suggested that ghrelin does
not act via central mechanisms to regulate PRL secretion in this
species, although a direct effect on the pituitary lactotropes
cannot be ruled out.
GHRELIN EXPRESSION IN THE OVARY
Expression of GHS-R1a in the ovary
The fully functional GHS-R1a was found in human (66, 67),
sheep (68), pig (69, 70), and chicken (71) ovaries. In cyclic
human ovary, expression of GHS-R1a showed a wider pattern of
tissue distribution, with detectable specific signal in oocytes as
well as in somatic, follicular, and luteal cells from early, mature,
and regressing corpus luteum (CL). Of particular note was the
observation that expression of follicular GHS-R1a paralleled
follicle development with stronger immunostaining in granulosa
and theca layers of healthy antral follicles (66). Expression of
GHS-R1a was also detected in the cells of ovarian surface
epithelium (67). Interestingly, GHS-R1a was expressed in both
mRNA and protein levels in sheep oocytes and in pre-
implantation blastulas obtained from oocytes fertilized in vitro
(68). In the oocytes, the levels of GHS-R1a mRNA decreased
from the stage of germinal vesicle to meiotic metaphase II, then
increased immediately at the 2-cell stage formation and
remained stable until the blastocyst was ready for implantation.
GHS-R1a protein was detected in most abundant levels in the
plasma membrane. In pig ovary, mRNA expression of GHSR
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Effect of ghrelin on: Animal used Dose of ghrelin 
Hypothalamus Pituitary 
References 
rat 0.1 nmol/0.3µl 3 nM 
--- 
 GnRH 
 LH  
basal  LH,  FSH 
GnRH-induced  LH 
Furuta et al. (39)  
Fernandez-Fernandez et al.
(38, 44, 48) 
sheep 1, 5 and 20 µg ---  LH Iqbal et al. (40) 
human 50 µg  LHRH  LH Kluge et al. (42) 
monkeys 100–159 µg ---  LH Vulliemoz et al. (41) 
goldfish 0.001–10 nM ---  LH Unniappan and Peter (49) 
carp  
(Cyprinus carpio L.) 10
–7–10–6 M ---  LH Sokoowska-Mikolajczyk et al. (50) 
Table 1. Effect of ghrelin on hypothalamus and pituitary hormones secretion. á stimulation; â inhibition; --- not studied.
and protein expression of GHS-R1a were reported (70). In this
study, both GHSR and GHS-R1a expression were significantly
higher in ovarian follicles collected from normally cycling
animals than in those from pre-pubertal pigs and suggest ghrelin
sensitivity during porcine sexual maturation. In fragments of
chicken ovarian follicular wall, including theca and granulosa
cells, mRNA expression of GHS-R1a was detected by Sirotkin
et al. (71). Moreover, the following three splice variants of GHS-
R1a were expressed in chicken ovaries: first full-length type 1a
transcript (cGHS-R1a), a second variant termed cGHS-R1av
(with deletion of a 48-bp fragment of cGHS-R1a cDNA in the 5’
region of exon 2), and a third GHS-R1a isoform termed
cGHSRtv, 432-bp amplicon resulting from premature splicing of
exon 1, retention of a 126-bp fragment of intron I and premature
initiation of exon 2 (71).
Expression of ghrelin in the ovary
Strong ghrelin immunostaining was demonstrated in ovarian
hilus interstitial cells. In immuno-positive cells, cytoplasm was
uniformly stained in granular form, whereas cell nuclei were
immuno-negative (66). Otherwise, interstitial cells derived from
the human theca interna of atretic follicles failed to show specific
ghrelin immunostaining (66). Similarly, ghrelin signal was not
detected in human ovarian follicles at any developmental stage.
However, specific ghrelin immuno-reactivity was observed in
young (d 15-19) and mature (d 20-24) human CL, whereas
expression of the hormone disappeared from regressing luteal
tissue (64). However, in the rat, expression of ghrelin mRNA was
observed in the ovary throughout the whole estrous cycle,
although relative mRNA levels varied dependently on the stage of
the cycle, with lowest levels in proestruos and maximum values in
diestrous (72). Ghrelin protein expression was predominantly
located in the luteal compartment of the rat ovary; especially
intense in steroidogenic luteal cells of the current cycle. Cyclic
expression of ovarian ghrelin mRNA was disrupted by inhibition
of the preovulatory gonadotropin surge and subsequent ovulation
by administration of a potent GnRH antagonist (72). In adult ovine
ovary, ghrelin was immuno-localized in granulosa cells of ovarian
follicles at all developmental stages (primordial, primary,
secondary, pre-antral and antral) and in luteal cells of sheep corpus
luteum (73). In some sections, positive ghrelin and GHS-R1a
immuno-reaction in the oocyte was observed (74). Du et al. (74)
also pointed out that ghrelin gene and protein expression was seen
in sheep ovary with a detectable specific signal in oocytes and in
somatic follicular cells. In situ hybridization for ghrelin mRNA
showed a wide pattern of hybridization within the ovarian follicles
along with an observation that ghrelin mRNA was clearly visible
in oocytes, cumulus cells, granulosa and theca cells, as well as in
cells of the ovarian surface epithelium. The relative ghrelin
mRNA levels varied dependently on the stage of the cycle in
sheep, with the highest expression during the development of
corpora lutea and lowest during their regressing phase (74). In pig
ovary, ghrelin mRNA expression depended on the stage of the
estrous cycle, with lowest expression in proestrous and maximum
in estrous and diestrous (75). Likewise expression of ghrelin
mRNA and protein in ovarian follicles collected from pig during
pre-pubertal time and estrous normal cycle was observed (70).
Additionally, during a short, 24 h organ culture of porcine ovarian
follicles collected from pre-pubertal animals, ghrelin was secreted
into the culture medium in amounts 4.67 pg/ml (76). These results
were further confirmed by immunohistochemical analysis
showing a strong ghrelin immuno-reactivity in steroidogenic
luteal cells and granulosa cells. Moreover, increase in ghrelin
expression during porcine CL development up to maximum levels
in the late luteal phase was observed. Immuno-analysis showed
that along with CL development ghrelin protein localization was
seen in the cytoplasm of large luteal cells only. Intensity of
immuno-reaction increased with CL development (77).
The presence of ghrelin/GHS-R1a (Table 2) in various
ovarian cells suggests a potential role of ghrelin in the control of
several aspects of ovarian cell function such as: steroid hormone
secretion, cell proliferation or apoptosis.
DIRECT ACTION OF GHRELIN ON THE OVARIAN
FUNCTION
Ghrelin and steroid hormone secretion
Data concerning the role of ghrelin in ovarian hormone
secretion are different and depend on experimental model, animal
species as well as on their reproductive and/or endocrine status
(Table 3). Also, in co-culture of granulosa and theca cells collected
from pre-pubertal porcine ovarian follicles, exogenous ghrelin
induced estradiol (E2) secretion into culture medium (79). Our not
published study demonstrated opposite effect in cultured whole
ovarian follicles collected from estrous cycle pigs, where ghrelin
had inhibitory effect on estradiol secretion by reduced CYP19
expression. However, in chicken ovarian granulosa cells culture
ghrelin (fragments1-18) at 1-100 ng/ml stimulated secretion of
progesterone (P4), E2, insulin-like growth factor type I (IGF-I) and
arginine vasotocin (AVT) (79). In order to localize the active core
of the 28-amino acid molecule responsible for hormonal activity of
ghrelin, two fragments 1-5; 1-18 and the whole molecule were
added separately each to the culture medium. Dependently on the
dose applied, the effect of ghrelin action on rabbit granulosa cells
culture stimulated secretion of P4 (1 ng/ml), IGF-I (100 ng/ml)
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Expression of GHS-R1a Expression of ghrelin 
Animal used 
mRNA protein mRNA protein
References 
human --- + --- + Gaytan et al. (66, 67)
pig + + + + 
Zhang et al. (48) 
Rak et al. (69)
Rak-Mardyla and Gregoraszczuk (70) 
rat --- --- + + Caminos et al. (72)
chicken + --- + --- Sirotkin et al. (71)
sheep --- + + + Miller et al. (73) Du et al. (68, 74) 
Table 2. Expression of ghrelin mRNA and protein and its receptor - GHS-R1a in ovary of different species. + detected; --- not studied.
while decreased P4 at 10 ng/ml, IGF-I at 10 ng/ml and testosterone
(T) at 1–10 ng/ml (81). Ghrelin pre-treatment of animals resulted
in suppression or even reversal of subsequent LH and IGF-I effects
on P4, E2 and IGF-I secretion by cultured rabbit granulosa cells
(82). On the other hand, in cultured human luteinizing granulosa
cells collected from women with infertility due to unilateral or
bilateral tubal disorder, ghrelin had an inhibitory effect on P4 and
E2 secretion (82). Similarly, injection of ghrelin during the estrous
cycle in rats reduced the serum concentration of E2 and P4 and the
expression of receptors ER (b) and PR (A+B) in the ovary (83). In
porcine cultured CL, ghrelin at 100 up to1000 pg/ml doses
decreased P4 secretion via inhibition of 3b-HSD activity and
protein expression (77). Similarly, in human mid-luteal cells,
ghrelin reduced basal and hCG-stimulated P4 secretion, decreased
luteotropic prostaglandin PGE2 release and increased luteolytic
PGF2a levels (85). This suggests that the imbalance between
luteotropic and luteolytic factors could be a mechanism by which
ghrelin negatively influenced luteal function into luteolysis (84).
Data of Romani et al. (85) showed that in cultured human luteal
cells culture P4 and VEGF release were significantly reduced by
unacylated ghrelin. They suggested that similar to ghrelin,
unacylated ghrelin might play a role in regulating the luteal cell
function that affected both luteal steroidogenesis and
luteotrophic/luteolytic imbalance. Most of these studies suggest
inhibitory action of ghrelin on ovarian steroidogenesis. A similar
inhibitory effect of ghrelin was observed in pre-implantation
mouse embryos development (86, 87).
Ghrelin and ovarian apoptosis
In the ovary, massive cell death occurs during neonatal and
postnatal life as an integral part of the normal ovarian
development. According to evidence from animal studies,
ghrelin has an anti-apoptotic effect in the ovary. In porcine
ovarian cells collected from pre-pubertal animals, ghrelin
inhibited cell apoptosis by decreasing caspase-3 activity and
DNA fragmentation (78). In chicken ovarian granulosa cells,
ghrelin decreased expression of caspase-3, bax, bcl-2 and
TUNEL-positive cells (71). Granulosa cells isolated from
ovaries of ghrelin-treated rabbits showed lower expression of
TdT (terminal deoxynucleotidyltransferase), than control
animals (81). Moreover, the rates of DNA fragmentation, as
estimated by detection of bromodeoxyuridine labeled DNA
fragments and TUNEL assay were reduced in the presence of
ghrelin in porcine ovarian cells (78). Additionally, antioxidant
properties of ghrelin in the rat ovary were observed by
Kheradmand et al. (88), who demonstrated that antioxidant
enzyme activity assays as well as measurement of glutathione
content and thiobarbituric acid reactive substances level reduced
significantly in the ghrelin-exposed animals. Furthermore,
Kheradmand et al. (89) demonstrated that the number of CL was
significantly lower and the number of ovarian follicles was
higher in the ghrelin treated group than that in the control.
Electron microscopic analysis also indicated some intracellular
changes associated with apoptosis and cell death such as
presence of secondary lysosome, apoptotic bodies, nuclear
chromatin condensation as well as margination, nuclear
segmentation and vacuolization of cytoplasm of granulosa and
theca cells (89). These studies indicate that ghrelin acts as a
survival factor by regulating anti-apoptotic effects in ovarian
cells. Ovarian follicular atresia is induced by activation of both
the extrinsic (death receptor) and intrinsic (mitochondrial)
pathways in ovary (90). However, mechanism(s) of anti-
apoptotic action of ghrelin need further investigation.
Ghrelin and ovarian proliferation
Studies have reported that ghrelin has a direct effect on
ovarian cell proliferation; for example, in pig (78), chicken (71),
and rabbit ovaries (81), ghrelin increased cell proliferation. In
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 cyclin B1 
Sirotkin and Meszarosova 
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rabbit 
ovarian fragments 1–28 1, 10, 100 ng/ml  P4, – E2  IGF-I  TUNEL  PCNA Sirotkin et al. (81) 
human granulosa 
lutein cells 1–28 
10–11 – 10–7
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 P4,  E2 --- --- --- Viani et al. (82) 




--- --- Tropea et al. (84) 
porcine luteal cells 1–28 100, 250, 500, 1000 pg/ml 
 P4 
 3β HSD 
--- --- --- Rak-Mardyla et al. (77) 
P4, progesterone; T, testosterone; E2, estradiol; GH, growth hormone; IGF-I, insulin-like growth factor type 1; PGF, prostaglandin;
VEGF, vascular endothelial growth factor; AVT, arginine vasotocin; PCNA, proliferating cell nuclear antigen.
Table 3. Effect of ghrelin on ovarian function: hormone secretion, apoptosis and proliferation in various species. á stimulation; â
inhibition; --- not studied.
both granulosa cells and lysates of whole ovarian chicken
follicular walls, ghrelin treatment induced markers of cell
proliferation: PCNA (proliferating cell nuclear antigen), a marker
of the S/phase of the cell cycle, and cyclin B1, a marker of the
G2/phase (71, 91). Moreover, granulosa cells from ghrelin-
treated rabbits had higher expression of PCNA than those from
control animals (81). This observation is consistent with previous
reports indicating that in co-culture of porcine granulosa and
theca cells, exogenous ghrelin significantly increased cell
proliferation (78). The above observations indicate that ghrelin
stimulated ovarian cell proliferation, which is an important
process in ovarian function, since the release of oocytes and
production of hormones are required for female reproduction.
Ghrelin and activation of GHS-R1a
In cultured porcine ovarian follicles, some ghrelin effects on
ovarian function were mediated by GHS-R1a (69). Recently, it was
demonstrated that ghrelin receptor antagonist, (D-Lys-3)-GHRP-6
prevents the stimulatory effect of ghrelin on aromatase activity,
estradiol secretion and cell proliferation (59). In contrast, the
inhibitory action of ghrelin on ovarian apoptosis was not affected
by (D-Lys-3)-GHRP-6, suggesting that ghrelin is able to control
ovarian apoptosis independent of GHS-R1a, since caspase-3
activity was not reversed by a selective antagonist of GHS-R1a
(69). Moreover, Sirotkin et al. (92) demonstrated, that (D-Lys3)-
GHRP-6 added alone at 1, 10 and 100 ng/ml to the porcine
granulosa cells culture promotes all markers of cell proliferation
(PCNA, cyclin B1 and MAPK/ERK1,2), inhibits all markers of
apoptosis (bax, p53 and caspase-3) and stimulates the release of all
three steroid hormones: progesterone, testosterone and estradiol.
They suggested that similar effects of (D-Lys3)-GHRP-6 (inhibitor
of GHS-R1a) and ghrelin 1-18 (its stimulator) on porcine ovaries
are not mediated by GHS-R1a but by sites other than GHS-R1a
(92). Some studies suggest that, which are released into the
duodenal lumen in response to food ingestion, could stimulate
pancreatic enzyme secretion through activation of entero-
pancreatic reflex via cholecystokinin release (93). Also, motor and
secretory activity, as well as the rhythm of cell proliferation in the
gastrointestinal tract and liver, are subject to many circadian
rhythms, mediated by autonomic cells and ghrelin (94).
Intracellular mechanism of ghrelin action
Mitogen activated protein kinases (MAPKs) and
triphosphoinositol (PI-3) kinase are serine/threonine kinases
mainly involved in the activation of nuclear transcription factors
that control cell proliferation, cell differentiation and apoptosis.
There is increasing evidence that PI-3 kinase is widely involved
in the survival of cells and activates an intracellular serine kinase
Akt/PKB, acting via inhibition of caspases activity (95, 96). Both
PI-3 kinase and MAPK not only regulate cell apoptosis and cell
survival, but also regulate ovarian hormone secretion (97). In
porcine ovarian cells, ghrelin significantly increased phospho-
ERK 1/2 (extracellular signal-regulated kinases) and PI-3 kinase
activity and protein expression in a dose and time dependent
manner, where the maximum effect was observed after 15 min of
cell incubation (98). Moreover, ovarian cells treated with ghrelin
together with selective inhibitors of ERK 1/2 (PD098059) and PI-
3 kinase (wortmannin), cell proliferation and apoptosis returned
to control levels, suggesting participation of the ERK 1,2 and PI-
3 kinase pathways in ghrelin-mediated cell proliferation and
apoptosis (98). Next, Popelkova et al. (99) reported that ghrelin
increased the level of phosphorylated MAPK expression in
bovine oocytes in vitro. Immunocytochemical analysis showed
that in chicken ovarian cells, ghrelin increased MAPK/ERK 1,2
levels (100). Additionally, in hamster ovarian cells, ghrelin
stimulated the phosphorylation of ERK 1,2 in a time and dose
responsive manner with maximum effect observed after 5 and 10
min of cell incubation (101). In chicken ovarian cells, Sirotkin et
al. (100) suggested that MAPK, tyrosine kinases and cyclic-
dependent protein kinases could also be regulators of avian
ovarian secretion and intracellular mediators of ghrelin action in
the ovary. However, in the next study Sirotkin et al. (102)
suggested that MAPK is probably not a mediator of ghrelin and
obestatin effect on porcine oocyte nuclear maturation. On the
other hand, Bai et al. (103) observed that ERK1,2 and p90 rsk
pathway was associated with maturation of ovis aries oocyte in
vitro. Ghrelin is a hormone that activates ERK and PI-3 kinase
survival signaling pathways in ovarian follicular cells. Most
recently, it has been shown that ERK controlled the first step in
synthesis of nucleotides for production of DNA and RNA, and
consequently affected cell survival and proliferation.
Additionally, PI-3 kinase is a general mediator of cell survival
and has been shown to regulate the activity of transcription
factors and modulate protein members of the Bcl2 family, thus
preventing the pro-apoptotic action of caspases. The ghrelin-
mediated activation of both ERKs and PI-3 kinase resulted in
stimulation of cell proliferation and inhibition of apoptosis in
ovarian follicular cells. Next intracellular mechanism of ghrelin
action was observed by Chrenek et al. (104), who examined
whether cyclic adenosine monophosphate (cAMP) regulated
ghrelin effects on ovarian cell steroidogenesis. It was observed,
that administration of a cAMP analog (dbcAMP) inverted the
inhibitory effect of ghrelin on progesterone secretion, but not of
estradiol release by isolated ovarian fragments, suggesting the
involvement of cAMP-dependent intracellular mechanisms in
down-regulation of rabbit ovarian steroidogenesis and in
modification, but not in mediating effect of ghrelin on ovarian
steroid hormones release (104).
SUMMARY
This mini-review presents selected aspects of ghrelin role in
hypothalamus, pituitary and ovarian functions. Although ghrelin
is a peptide hormone secreted from the stomach, the fact that its
functional receptor, GHS-R1a, is also expressed in the
hypothalamic-pituitary-gonadal axis and that ghrelin is
synthesized in the ovary in many species suggests its role as
local, autocrine and/or paracrine regulators in several aspects of
reproduction. Increasing data show that ghrelin has inhibitory
effect on gonadotropins and PRL secretions. Some studies
suggest an indirect action of ghrelin, since ghrelin acts as a
central orexigenic signal by NPY, AgRP or orexin, which in turn
plays an inhibitory role in central hypothalamus-pituitary-
gonads axis control. Interaction between leptin and ghrelin has
influence on the reproductive and food intake axes, which
includes interactions with neuropeptides that are also involved in
the reproduction. Down-regulation of kisspeptin expression may
play a critical role in the transduction of ghrelin-induced
suppression of reproduction function often observed during
calorific restriction. Available data show that ghrelin directly
regulates ovarian functions, such as steroid synthesis, cell
apoptosis or proliferation. Reproductive effects are highly
dependent on the body energy status. Finally, the study suggests
that ghrelin, acting at central and peripheral level, could be one
of the signal mechanisms linking nutritional balance and
hypothalamus-pituitary-ovarian axis.
Abbreviations: ACTH, adrenocorticotropic hormone; AgRP,
aqouti-related protein, ARC, arcuate nucleus; AVT, arginine
vasotocin; CART, cocaine- and amphetamine-regulated
transcript; CL, corpus luteum; E2, estradiol; ERK 1/2,
700
extracellular signal-regulated kinases; FSH, follicle-stimulating
hormone; GH, growth hormone; GHSR, growth hormone
secretagogue receptor; GnRH, gonadotropin-realesing hormone;
IGF-I, insulin-like growth factor type I; LH, luteinizing hormone;
MAPK, mitogen activated protein kinases; NPY, neuropeptide Y;
P4, progesterone; PCNA, proliferating cell nuclear antigen; PI-3,
triphosphoinositol; PLC, phospholipase C; POMC, pro-
opiomelanocortin; PRL, prolactin; TdT, terminal
deoxynucleotidyltransferase.
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